G. Gallant
Impact in
-
- Cancer survivorship and care
- Cancer Diagnosis and Treatment
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
-
- Phagocytosis and Immune Regulation
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 4
- Neutropenia and Cancer Infections 3
- PARP inhibition in cancer therapy 2
-
- Cell death mechanisms and regulation 4
- Cancer therapeutics and mechanisms 2
- Co-authors
- Hélène Dulude (9 shared papers)Markus Moehler (1 shared paper)Christian Schulz (1 shared paper)Stephan Kanzler (1 shared paper)Vesna Šneller (1 shared paper)Volker Heinemann (1 shared paper)Tanja Trarbach (1 shared paper)C.-H. Köhne (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)European Journal of Cancer (3 papers)British Journal of Cancer (2 papers)Antiviral chemistry & chemotherapy (1 paper)Lung Cancer (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
G. Gallant
21 papers receiving 369 citations
Peers
Comparison fields: 5 of 69
- Oncology 140
- Immunology 53
- Molecular Biology 178
- Pathology and Forensic Medicine 42
- Cancer Research 30
Countries citing papers authored by G. Gallant
This map shows the geographic impact of G. Gallant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Gallant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Gallant more than expected).
Fields of papers citing papers by G. Gallant
This network shows the impact of papers produced by G. Gallant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Gallant. The network helps show where G. Gallant may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Gallant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 150 | |
| 2 | Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. | 1998 | 76 |
| 3 | 2011 | 33 | |
| 4 | 1998 | 26 | |
| 5 | 2010 | 22 | |
| 6 | 1998 | 19 | |
| 7 | 1991 | 8 | |
| 8 | 2010 | 8 | |
| 9 | 1996 | 7 | |
| 10 | Human agonistic anti-TRAIL receptor antibodies, HGS-ETR1 and HGS-ETR2, induce apoptosis in diverse hematological tumor lines | 2003 | 5 |
| 11 | In vitro cytotoxicity and differential cellular sensitivity of new N-methyl and N-propargyl urea and nitrosourea derivatives of diamino acids against sixty human NCI tumor cell lines. | 1993 | 3 |
| 12 | 1999 | 3 | |
| 13 | 1998 | 3 | |
| 14 | 1997 | 2 | |
| 15 | In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. I. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl ureas. | 1995 | 2 |
| 16 | Synthesis and preliminary in vitro cytotoxicity evaluation of 1,3-bis-(2-propynyl)-1-nitrosourea (BPNU) and derivatives. | 1995 | 2 |
| 17 | 進行性NSCLC患者におけるカルボプラチンとパクリタキセルを併用した,TRAIL-R1アゴニスト単クローン抗体マパツムマブの無作為化第2相試験 | 2010 | 1 |
| 18 | 2024 | 1 | |
| 19 | 1999 | 1 | |
| 20 | 2003 | 1 |
About G. Gallant
G. Gallant is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Organic Chemistry, having authored 21 papers that have together received 374 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers), Neutropenia and Cancer Infections (3 papers), Ferrocene Chemistry and Applications (2 papers), PARP inhibition in cancer therapy (2 papers), Cancer therapeutics and mechanisms (2 papers) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (140 citations), Immunology (53 citations), Molecular Biology (178 citations), Pathology and Forensic Medicine (42 citations) and Cancer Research (30 citations). G. Gallant has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Hélène Dulude, Markus Moehler, Christian Schulz, Stephan Kanzler, Vesna Šneller, Volker Heinemann, Tanja Trarbach, C.-H. Köhne, Neil A. Hagen and Kathy Spachynski. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer, Antiviral chemistry & chemotherapy and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.